title: Successful etretinate treatment of recurrent keratoacanthomas on a skin graft: Case report.
authors.affiliation: Department of Dermatology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
authors.forename: Rie
authors.initials: R
authors.lastname: Nishibaba
authors.affiliation: Department of Dermatology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
authors.forename: Yuko
authors.initials: Y
authors.lastname: Higashi
authors.affiliation: Department of Dermatology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
authors.forename: Kentaro
authors.initials: K
authors.lastname: Mera
authors.affiliation: Department of Dermatology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
authors.forename: Takuro
authors.initials: T
authors.lastname: Kanekura
mesh_terms: D000284:Administration, Oral; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage; D002117:Calcitriol / Q000008:administration & dosage / Q000031:analogs & derivatives; D062109:Dermatologic Surgical Procedures; D019008:Drug Resistance, Neoplasm; D005050:Etretinate / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007636:Keratoacanthoma / Q000473:pathology / Q000628:therapy*; D007641:Keratolytic Agents / Q000627:therapeutic use*; D007866:Leg; D009364:Neoplasm Recurrence, Local / Q000473:pathology / Q000628:therapy*; D009824:Ointments; D012867:Skin / Q000473:pathology*; D012878:Skin Neoplasms / Q000473:pathology / Q000628:therapy*; D016038:Skin Transplantation / Q000009:adverse effects; D019737:Transplants / Q000473:pathology* / Q000601:surgery; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D007641:Keratolytic Agents; D009824:Ointments; D005050:Etretinate; D002117:Calcitriol; C051883:maxacalcitol